Rob Holgate, PhD

VP of Research & Innovation at Abzena

Speaker

Rob has over 20 years experience in Drug Discovery and early stage Development. After obtaining his PhD in Molecular Medicine at UCL, he moved to The University of York as a post-doctoral researcher. He subsequently worked at Cambridge Antibody Technology (now part of AZ) where he was a Senior Scientist within Antibody Engineering then Team Leader of the High Throughput Expression team. Rob joined Antitope (now Abzena) in 2008 as a Research Manager and now leads Abzena’s Discovery and Protein Engineering group overseeing Abzena’s antibody discovery, antibody humanization, protein deimmunisation and bespoke engineering projects.